Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-04-17

Clinical Trial Update: The Diagnostic Benefits of the HyperQTM System in ECG Stress Testing [Phase 3]

View source ↗

Summary

A Phase 3 trial update evaluating the HyperQ System for diagnosing myocardial ischemia during ECG stress testing is presented; the trial status is currently UNK…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Assuta Hospital Systems | Conditions: Myocardial Ischemia | Phase 3 | Status: UNKNOWN